Breast Cancer and HER2: eMedicine Genomic Medicine
Links shared publicly online about this topic.
- 1,123total visits
Breast Cancer and HER2: eMedicine Genomic Medicine
Overview: Approximately 30% of malignant breast cancers demonstrate overamplification of the human epidermal receptor type 2 (HER2) gene, resulting in an overexpression of the HER2 receptor, a transmembrane tyrosine kinase receptor within the epidermal growth factor receptor ...
View full resource at emedicine.medscape.com
Tags: Cancer, Breast Cancer, Genes, Women's Health, Genomic Medicine
Most Recently Shared on June 2, 2010 at 7:27 pm By:
About 30% of malignant breast cancers demonstrate overamplification of the HER2 gene. http://bit.ly/bXI1EO
Tamoxifen Metabolism and CYP2D6: eMedicine Genomic Medicine
emedicine.medscape.com — “Overview: Adjuvant therapy with tamoxifen has been the standard approach for reducing risk of recurrence in women with estrogen-receptor (ER) positive breast cancer since the early 1980s. Long-term data demonstrate that the use of tamoxifen reduces recurrence and ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:23 pm By:
Susan Scroggins Active Health Library and Health Advocate
Learn about tamoxifen (a chemotherapy medication) metabolism and CYP2D6. http://bit.ly/cM2RiB
Advertisement
